BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Fletcher CD. Pleomorphic malignant fibrous histiocytoma: fact or fiction? A critical reappraisal based on 159 tumors diagnosed as pleomorphic sarcoma. Am J Surg Pathol. 1992;16:213-228. [PMID: 1317996 DOI: 10.1097/00000478-199203000-00001] [Cited by in Crossref: 341] [Cited by in F6Publishing: 187] [Article Influence: 11.8] [Reference Citation Analysis]
Number Citing Articles
1 Sandberg AA. Updates on the cytogenetics and molecular genetics of bone and soft tissue tumors: liposarcoma. Cancer Genetics and Cytogenetics 2004;155:1-24. [DOI: 10.1016/j.cancergencyto.2004.08.005] [Cited by in Crossref: 119] [Cited by in F6Publishing: 77] [Article Influence: 7.0] [Reference Citation Analysis]
2 Carneiro A, Francis P, Bendahl PO, Fernebro J, Akerman M, Fletcher C, Rydholm A, Borg A, Nilbert M. Indistinguishable genomic profiles and shared prognostic markers in undifferentiated pleomorphic sarcoma and leiomyosarcoma: different sides of a single coin? Lab Invest 2009;89:668-75. [PMID: 19290004 DOI: 10.1038/labinvest.2009.18] [Cited by in Crossref: 36] [Cited by in F6Publishing: 27] [Article Influence: 3.0] [Reference Citation Analysis]
3 Borek BT, Mckee PH, Freeman JA, Maguire B, Brander WL, Calonje E. Primary Malignant Melanoma With Rhabdoid Features: A Histologic and Immunocytochemical Study of Three Cases: . The American Journal of Dermatopathology 1998;20:123-7. [DOI: 10.1097/00000372-199804000-00003] [Cited by in Crossref: 51] [Cited by in F6Publishing: 26] [Article Influence: 2.2] [Reference Citation Analysis]
4 Hollmig TS, Kirkland BE, Henderson MT, Tang JY, Gladstone HB. The Evolving Conception and Management Challenges of Malignant Fibrous Histiocytoma. Dermatologic Surgery 2012;38:1922-9. [DOI: 10.1111/j.1524-4725.2012.02538.x] [Cited by in Crossref: 11] [Cited by in F6Publishing: 5] [Article Influence: 1.2] [Reference Citation Analysis]
5 Meister P. Malignant Fibrous Histiocytoma: A “Fibrohistiocytic” or Primitive, Fibroblastic Sarcoma. In: Harms D, Schmidt D, editors. Soft Tissue Tumors. Berlin: Springer Berlin Heidelberg; 1995. pp. 193-214. [DOI: 10.1007/978-3-642-77289-4_10] [Cited by in Crossref: 9] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
6 Merchant W, Calonje E, Fletcher C. Inflammatory leiomyosarcoma: a morphological subgroup within the heterogeneous family of so-called inflammatory malignant fibrous histiocytoma. Histopathology 1995;27:525-32. [DOI: 10.1111/j.1365-2559.1995.tb00323.x] [Cited by in Crossref: 54] [Cited by in F6Publishing: 33] [Article Influence: 2.1] [Reference Citation Analysis]
7 Mori A, Tagawa T, Kamei T, Murata T, Inui M, Ohse S. Characterization of four cell lines derived from a human malignant fibrous histiocytoma of the maxillary sinus. Oral Oncology 2001;37:527-36. [DOI: 10.1016/s1368-8375(01)00004-5] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
8 Skubitz KM, Skubitz AP. Characterization of sarcomas by means of gene expression. Journal of Laboratory and Clinical Medicine 2004;144:78-91. [DOI: 10.1016/j.lab.2004.04.005] [Cited by in Crossref: 32] [Cited by in F6Publishing: 28] [Article Influence: 1.9] [Reference Citation Analysis]
9 Wang R, Lu YJ, Fisher C, Bridge JA, Shipley J. Characterization of chromosome aberrations associated with soft-tissue leiomyosarcomas by twenty-four-color karyotyping and comparative genomic hybridization analysis. Genes Chromosomes Cancer 2001;31:54-64. [PMID: 11284036 DOI: 10.1002/gcc.1118] [Cited by in Crossref: 42] [Cited by in F6Publishing: 35] [Article Influence: 2.1] [Reference Citation Analysis]
10 Kaddu S, Wolf I, Horn M, Kerl H. Epithelioid sarcoma with angiomatoid features: report of an unusual case arising in an elderly patient within a burn scar. J Cutan Pathol 2008;35:324-8. [DOI: 10.1111/j.1600-0560.2007.00802.x] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
11 Roland CL, Wang W, Lazar AJ, Torres KE. Myxofibrosarcoma. Surgical Oncology Clinics of North America 2016;25:775-88. [DOI: 10.1016/j.soc.2016.05.008] [Cited by in Crossref: 30] [Cited by in F6Publishing: 17] [Article Influence: 6.0] [Reference Citation Analysis]
12 Donsbeck, Ranchere, Coindre, Le Gall, Cordier, Loire. Primary cardiac sarcomas: an immunohistochemical and grading study with long-term follow-up of 24 cases: Primary cardiac sarcomas. Histopathology 1999;34:295-304. [DOI: 10.1046/j.1365-2559.1999.00636.x] [Cited by in Crossref: 128] [Cited by in F6Publishing: 77] [Article Influence: 6.4] [Reference Citation Analysis]
13 Ziemer M. Atypical fibroxanthoma. J Dtsch Dermatol Ges 2012;10:537-50. [PMID: 22709412 DOI: 10.1111/j.1610-0387.2012.07980.x] [Cited by in Crossref: 4] [Cited by in F6Publishing: 8] [Article Influence: 0.4] [Reference Citation Analysis]
14 Coindre JM, Terrier P, Guillou L, Le Doussal V, Collin F, Ranchère D, Sastre X, Vilain MO, Bonichon F, N'Guyen Bui B. Predictive value of grade for metastasis development in the main histologic types of adult soft tissue sarcomas: a study of 1240 patients from the French Federation of Cancer Centers Sarcoma Group. Cancer 2001;91:1914-26. [PMID: 11346874 DOI: 10.1002/1097-0142(20010515)91:10<1914::aid-cncr1214>3.0.co;2-3] [Cited by in Crossref: 434] [Cited by in F6Publishing: 107] [Article Influence: 21.7] [Reference Citation Analysis]
15 Calonje E. Soft-Tissue Tumours and Tumour-like Conditions. In: Burns T, Breathnach S, Cox N, Griffiths C, editors. Rook's Textbook of Dermatology. Oxford: Wiley-Blackwell; 2010. pp. 1-62. [DOI: 10.1002/9781444317633.ch56] [Cited by in Crossref: 14] [Cited by in F6Publishing: 2] [Article Influence: 1.3] [Reference Citation Analysis]
16 Binh MBN, Sastre-garau X, Guillou L, Pinieux GD, Terrier P, Lagacé R, Aurias A, Hostein I, Coindre JM. MDM2 and CDK4 Immunostainings Are Useful Adjuncts in Diagnosing Well-Differentiated and Dedifferentiated Liposarcoma Subtypes: A Comparative Analysis of 559 Soft Tissue Neoplasms With Genetic Data. American Journal of Surgical Pathology 2005;29:1340-7. [DOI: 10.1097/01.pas.0000170343.09562.39] [Cited by in Crossref: 415] [Cited by in F6Publishing: 233] [Article Influence: 25.9] [Reference Citation Analysis]
17 Biselli R, Boldrini R, Ferlini C, Boglino C, Inserra A, Bosman C. Myofibroblastic tumours: neoplasias with divergent behaviour. Ultrastructural and flow cytometric analysis. Pathol Res Pract 1999;195:619-32. [PMID: 10507082 DOI: 10.1016/S0344-0338(99)80127-7] [Cited by in Crossref: 52] [Cited by in F6Publishing: 9] [Article Influence: 2.4] [Reference Citation Analysis]
18 Calonje E, Fletcher CD. Immunohistochemistry and DNA Flow Cytometry in Soft-Tissue Sarcomas. Hematology/Oncology Clinics of North America 1995;9:657-76. [DOI: 10.1016/s0889-8588(18)30090-x] [Cited by in Crossref: 4] [Article Influence: 0.2] [Reference Citation Analysis]
19 Nicolas MM, Tamboli P, Gomez JA, Czerniak BA. Pleomorphic and dedifferentiated leiomyosarcoma: clinicopathologic and immunohistochemical study of 41 cases. Human Pathology 2010;41:663-71. [DOI: 10.1016/j.humpath.2009.10.005] [Cited by in Crossref: 42] [Cited by in F6Publishing: 20] [Article Influence: 3.8] [Reference Citation Analysis]
20 Van Der Bijl AE, M. Taminiau AH, Hermans J, Beerman H, W. Hogendoorn PC. Accuracy of the Jamshidi Trocar Biopsy in the Diagnosis of Bone Tumors: . Clinical Orthopaedics and Related Research 1997;334:233???243. [DOI: 10.1097/00003086-199701000-00030] [Cited by in Crossref: 18] [Cited by in F6Publishing: 11] [Article Influence: 0.8] [Reference Citation Analysis]
21 Kilpatrick SE, Ward WG. Myxofibrosarcoma of soft tissues: cytomorphologic analysis of a series. Diagn Cytopathol 1999;20:6-9. [PMID: 9884819 DOI: 10.1002/(sici)1097-0339(199901)20:1<6::aid-dc2>3.0.co;2-b] [Cited by in Crossref: 34] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
22 Oliveira AM, Scheithauer BW, Salomao DR, Parisi JE, Burger PC, Nascimento AG. Primary Sarcomas of the Brain and Spinal Cord: A Study of 18 Cases. The American Journal of Surgical Pathology 2002;26:1056-63. [DOI: 10.1097/00000478-200208000-00011] [Cited by in Crossref: 33] [Cited by in F6Publishing: 16] [Article Influence: 1.7] [Reference Citation Analysis]
23 de Saint Aubain Somerhausen N, Fletcher C. Soft-tissue sarcomas: an update. European Journal of Surgical Oncology (EJSO) 1999;25:215-20. [DOI: 10.1053/ejso.1998.0630] [Cited by in Crossref: 28] [Cited by in F6Publishing: 16] [Article Influence: 1.3] [Reference Citation Analysis]
24 Rydholm A, Gustafson P, Alvegård TA, Saeter G, Blomqvist C. Prognostic factors in soft tissue sarcoma: A review and the Scandinavian Sarcoma Group experience. Acta Orthopaedica Scandinavica 2016;70:50-7. [DOI: 10.1080/17453674.1999.11744824] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 1.4] [Reference Citation Analysis]
25 Nilbert M, Mandahl N, Åman P, Rydholm A, Mitelman F. No rearrangements of the CHOP gene in malignant fibrous histiocytoma. Cancer Genetics and Cytogenetics 1994;72:155-6. [DOI: 10.1016/0165-4608(94)90133-3] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.2] [Reference Citation Analysis]
26 Al-nafussi A. Spindle cell tumours of the breast: practical approach to diagnosis: Spindle cell tumours of the breast. Histopathology 1999;35:01-13. [DOI: 10.1046/j.1365-2559.1999.00766.x] [Cited by in Crossref: 73] [Cited by in F6Publishing: 35] [Article Influence: 4.1] [Reference Citation Analysis]
27 Mizukami H, Yajima N, Wada R, Matsumoto K, Kojima M, Klöppel G, Yagihashi S. Pancreatic malignant fibrous histiocytoma, inflammatory myofibroblastic tumor, and inflammatory pseudotumor related to autoimmune pancreatitis: characterization and differential diagnosis. Virchows Arch 2006;448:552-60. [DOI: 10.1007/s00428-006-0157-x] [Cited by in Crossref: 27] [Cited by in F6Publishing: 22] [Article Influence: 1.8] [Reference Citation Analysis]
28 Li YR, Akbari E, Tretiakova MS, Hart J, Akbari M, Urbanski SJ, Gao ZH. Primary hepatic malignant fibrous histiocytoma: clinicopathologic characteristics and prognostic value of ezrin expression. Am J Surg Pathol. 2008;32:1144-1158. [PMID: 18545143 DOI: 10.1097/pas.0b013e3181659791] [Cited by in Crossref: 26] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
29 Katenkamp D, Kosmehl H. Heterogeneity in malignant soft tissue tumors. Curr Top Pathol 1995;89:123-51. [PMID: 7882706 DOI: 10.1007/978-3-642-77289-4_7] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.1] [Reference Citation Analysis]
30 Engellau J. Prognostic factors in soft tissue sarcomaTissue microarray for immunostaining, the importance of whole-tumor sections and time-dependence. Acta Orthopaedica Scandinavica 2009;75:1-52. [DOI: 10.1080/03008820410001887] [Cited by in Crossref: 9] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
31 Watanabe K, Tajino T, Sekiguchi M, Suzuki T. h-Caldesmon as a Specific Marker for Smooth Muscle Tumors. American Journal of Clinical Pathology 2000;113:663-8. [DOI: 10.1309/jnqx-f4km-q0q0-7xk8] [Cited by in Crossref: 49] [Cited by in F6Publishing: 11] [Article Influence: 8.2] [Reference Citation Analysis]
32 Kumagai D, Yamate J, Tajima T, Tsukamoto Y, Yasui H, Kuwamura M, Kotani T, Sakuma S. Distribution of Cells Labelled by a Monoclonal Antibody (A3) against a Cloned Cell Line derived from a Rat Malignant Fibrous Histiocytoma. Journal of Comparative Pathology 2000;123:77-87. [DOI: 10.1053/jcpa.2000.0389] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 0.4] [Reference Citation Analysis]
33 Henderson MT, Hollmig ST. Malignant fibrous histiocytoma: Changing perceptions and management challenges. Journal of the American Academy of Dermatology 2012;67:1335-41. [DOI: 10.1016/j.jaad.2012.04.013] [Cited by in Crossref: 35] [Cited by in F6Publishing: 19] [Article Influence: 3.9] [Reference Citation Analysis]
34 Fletcher C. Haemangiopericytoma — A dying breed? Reappraisal of an ‘entity’ and its variants: a hypothesis. Current Diagnostic Pathology 1994;1:19-23. [DOI: 10.1016/s0968-6053(06)80005-0] [Cited by in Crossref: 87] [Article Influence: 3.2] [Reference Citation Analysis]
35 Hameed M. Pathology and genetics of adipocytic tumors. Cytogenet Genome Res 2007;118:138-47. [DOI: 10.1159/000108294] [Cited by in Crossref: 32] [Cited by in F6Publishing: 12] [Article Influence: 2.3] [Reference Citation Analysis]
36 Rydholm A. Prognostic factors in soft tissue sarcoma. Acta Orthop Scand Suppl 1997;273:148-55. [PMID: 9057607 DOI: 10.1080/17453674.1997.11744722] [Cited by in Crossref: 13] [Cited by in F6Publishing: 9] [Article Influence: 0.5] [Reference Citation Analysis]
37 Goh SGN, Dayrit JF, Calonje E. Sarcomatoid eccrine porocarcinoma: report of two cases and a review of the literature. J Cutan Pathol 2007;34:55-60. [DOI: 10.1111/j.1600-0560.2006.00556.x] [Cited by in Crossref: 23] [Cited by in F6Publishing: 12] [Article Influence: 1.6] [Reference Citation Analysis]
38 Bramwell VH, Steward WP, Nooij M, Whelan J, Craft AW, Grimer RJ, Taminau AH, Cannon SR, Malcolm AJ, Hogendoorn PC, Uscinska B, Kirkpatrick AL, Machin D, Van Glabbeke MM. Neoadjuvant Chemotherapy With Doxorubicin and Cisplatin in Malignant Fibrous Histiocytoma of Bone: A European Osteosarcoma Intergroup Study. JCO 1999;17:3260-9. [DOI: 10.1200/jco.1999.17.10.3260] [Cited by in Crossref: 57] [Cited by in F6Publishing: 7] [Article Influence: 2.6] [Reference Citation Analysis]
39 Toro JR, Travis LB, Wu HJ, Zhu K, Fletcher CD, Devesa SS. Incidence patterns of soft tissue sarcomas, regardless of primary site, in the surveillance, epidemiology and end results program, 1978-2001: An analysis of 26,758 cases. Int J Cancer. 2006;119:2922-2930. [PMID: 17013893 DOI: 10.1002/ijc.22239] [Cited by in Crossref: 345] [Cited by in F6Publishing: 237] [Article Influence: 23.0] [Reference Citation Analysis]
40 Oda Y, Miyajima K, Kawaguchi K, Tamiya S, Oshiro Y, Hachitanda Y, Oya M, Iwamoto Y, Tsuneyoshi M. Pleomorphic Leiomyosarcoma: Clinicopathologic and Immunohistochemical Study With Special Emphasis on Its Distinction From Ordinary Leiomyosarcoma and Malignant Fibrous Histiocytoma. The American Journal of Surgical Pathology 2001;25:1030-8. [DOI: 10.1097/00000478-200108000-00007] [Cited by in Crossref: 98] [Cited by in F6Publishing: 55] [Article Influence: 4.9] [Reference Citation Analysis]
41 Delisca GO, Mesko NW, Alamanda VK, Archer KR, Song Y, Halpern JL, Schwartz HS, Holt GE. MFH and high-grade undifferentiated pleomorphic sarcoma-what's in a name? J Surg Oncol 2015;111:173-7. [PMID: 25219789 DOI: 10.1002/jso.23787] [Cited by in Crossref: 17] [Cited by in F6Publishing: 8] [Article Influence: 2.4] [Reference Citation Analysis]
42 Lahat G, Zhang P, Zhu QS, Torres K, Ghadimi M, Smith KD, Wang WL, Lazar AJ, Lev D. The expression of c-Met pathway components in unclassified pleomorphic sarcoma/malignant fibrous histiocytoma (UPS/MFH): a tissue microarray study. Histopathology 2011;59:556-61. [PMID: 22034893 DOI: 10.1111/j.1365-2559.2011.03946.x] [Cited by in Crossref: 20] [Cited by in F6Publishing: 17] [Article Influence: 2.2] [Reference Citation Analysis]
43 Oda Y, Tamiya S, Oshiro Y, Hachitanda Y, Kinukawa N, Iwamoto Y, Tsuneyoshi M. Reassessment and clinicopathological prognostic factors of malignant fibrous histiocytoma of soft parts. Pathol Int 2002;52:595-606. [DOI: 10.1046/j.1440-1827.2002.01399.x] [Cited by in Crossref: 61] [Cited by in F6Publishing: 40] [Article Influence: 3.2] [Reference Citation Analysis]
44 Withers AH, Brougham ND, Barber RM, Tan ST. Atypical fibroxanthoma and malignant fibrous histiocytoma. Journal of Plastic, Reconstructive & Aesthetic Surgery 2011;64:e273-8. [DOI: 10.1016/j.bjps.2011.05.004] [Cited by in Crossref: 33] [Cited by in F6Publishing: 17] [Article Influence: 3.3] [Reference Citation Analysis]
45 Soleymani T, Aasi SZ, Novoa R, Hollmig ST. Atypical Fibroxanthoma and Pleomorphic Dermal Sarcoma. Dermatologic Clinics 2019;37:253-9. [DOI: 10.1016/j.det.2019.02.001] [Cited by in Crossref: 13] [Cited by in F6Publishing: 8] [Article Influence: 6.5] [Reference Citation Analysis]
46 Goodlad JR. Spindle-cell B-cell lymphoma presenting in the skin. Br J Dermatol 2001;145:313-7. [PMID: 11531800 DOI: 10.1046/j.1365-2133.2001.04323.x] [Cited by in Crossref: 32] [Cited by in F6Publishing: 20] [Article Influence: 1.6] [Reference Citation Analysis]
47 Deyrup AT, Haydon RC, Huo D, Ishikawa A, Peabody TD, He TC, Montag AG. Myoid differentiation and prognosis in adult pleomorphic sarcomas of the extremity: an analysis of 92 cases. Cancer 2003;98:805-13. [PMID: 12910526 DOI: 10.1002/cncr.11617] [Cited by in Crossref: 45] [Cited by in F6Publishing: 29] [Article Influence: 2.5] [Reference Citation Analysis]
48 Zhang B, Tomita Y, Ch'ng E, Qiu Y, He J, Jin YF, Tomoeda M, Hamada K, Ueda T, Aozasa K. Prognostic significance of phosphorylated FOXO1 expression in soft tissue sarcoma. Ann Surg Oncol 2009;16:1925-37. [PMID: 19408047 DOI: 10.1245/s10434-009-0481-x] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 0.8] [Reference Citation Analysis]
49 Engellau J, Akerman M, Anderson H, Domanski HA, Rambech E, Alvegård TA, Nilbert M. Tissue microarray technique in soft tissue sarcoma: immunohistochemical Ki-67 expression in malignant fibrous histiocytoma. Appl Immunohistochem Mol Morphol 2001;9:358-63. [PMID: 11759064 DOI: 10.1097/00129039-200112000-00012] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 0.6] [Reference Citation Analysis]
50 Khanfir K, Alzieu L, Terrier P, Le Péchoux C, Bonvalot S, Vanel D, Le Cesne A. Does adjuvant radiation therapy increase loco-regional control after optimal resection of soft-tissue sarcoma of the extremities? European Journal of Cancer 2003;39:1872-80. [DOI: 10.1016/s0959-8049(03)00426-x] [Cited by in Crossref: 57] [Cited by in F6Publishing: 10] [Article Influence: 3.2] [Reference Citation Analysis]
51 Sabah M, Cummins R, Leader M, Kay E. Leiomyosarcoma and malignant fibrous histiocytoma share similar allelic imbalance pattern at 9p. Virchows Arch 2005;446:251-8. [DOI: 10.1007/s00428-004-1190-2] [Cited by in Crossref: 14] [Cited by in F6Publishing: 8] [Article Influence: 0.9] [Reference Citation Analysis]
52 Murray EM, Werner D, Greeff EA, Taylor DA. Postradiation sarcomas: 20 cases and a literature review. Int J Radiat Oncol Biol Phys. 1999;45:951-961. [PMID: 10571202 DOI: 10.1016/s0360-3016(99)00279-5] [Cited by in Crossref: 106] [Cited by in F6Publishing: 26] [Article Influence: 4.8] [Reference Citation Analysis]
53 Leong AS, Vinyuvat S, Suthipintawong C, Leong FJ. Patterns of Basal Lamina Immunostaining in Soft-Tissue and Bony Tumors: . Applied Immunohistochemistry 1997;5:1-7. [DOI: 10.1097/00022744-199703000-00001] [Cited by in Crossref: 13] [Cited by in F6Publishing: 9] [Article Influence: 0.5] [Reference Citation Analysis]
54 Llombart B, Serra-Guillén C, Requena C, Alsina M, Morgado-Carrasco D, Machado I, Sanmartín O. Leiomyosarcoma and Pleomorphic Dermal Sarcoma: Guidelines for Diagnosis and Treatment. Actas Dermosifiliogr (Engl Ed) 2019;110:4-11. [PMID: 30409380 DOI: 10.1016/j.ad.2018.06.012] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 1.3] [Reference Citation Analysis]
55 Ceballos KM, Nielsen GP, Selig MK, O’connell JX. Is Anti–h-Caldesmon Useful for Distinguishing Smooth Muscle and Myofibroblastic Tumors? American Journal of Clinical Pathology 2000;114:746-53. [DOI: 10.1309/k5jp-a9en-uwn7-b5gg] [Cited by in Crossref: 87] [Cited by in F6Publishing: 14] [Article Influence: 4.1] [Reference Citation Analysis]
56 Iwasaki H, Nabeshima K, Nishio J, Jimi S, Aoki M, Koga K, Hamasaki M, Hayashi H, Mogi A. Pathology of soft-tissue tumors: Daily diagnosis, molecular cytogenetics and experimental approach. Pathology International 2009;59:501-21. [DOI: 10.1111/j.1440-1827.2009.02401.x] [Cited by in Crossref: 36] [Cited by in F6Publishing: 23] [Article Influence: 3.0] [Reference Citation Analysis]
57 Yamate J, Tajima M, Shibuya K, Saitoh T. Enhancement of lipid phagocytosis by cloned cells derived from rat malignant fibrous histiocytoma under hyperlipemic conditions. Pathology International 1994;44:735-44. [DOI: 10.1111/j.1440-1827.1994.tb02920.x] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
58 Collin F, Gelly-marty M, Bui Nguyen Binh M, Coindre J. Sarcomes des tissus mous : données anatomopathologiques actuelles. Cancer/Radiothérapie 2006;10:7-14. [DOI: 10.1016/j.canrad.2005.09.025] [Cited by in Crossref: 8] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
59 Fletcher CD. Malignant peripheral nerve sheath tumours. Curr Top Pathol 1995;89:333-54. [PMID: 7882718 DOI: 10.1007/978-3-642-77289-4_17] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 0.3] [Reference Citation Analysis]
60 Åkerman M. Malignant fibrous histiocytoma—the commonest soft tissue sarcoma or a nonexistent entity? Acta Orthopaedica Scandinavica 2016;68:41-6. [DOI: 10.1080/17453674.1997.11744701] [Cited by in Crossref: 20] [Cited by in F6Publishing: 7] [Article Influence: 4.0] [Reference Citation Analysis]
61 Le Doussal V, Coindre J, Leroux A, Hacene K, Terrier P, Bui NB, Bonichon F, Collin F, Mandard A, Contesso G. Prognostic factors for patients with localized primary malignant fibrous histiocytoma: A multicenter study of 216 patients with multivariate analysis. Cancer 1996;77:1823-30. [DOI: 10.1002/(sici)1097-0142(19960501)77:9<1823::aid-cncr10>3.0.co;2-1] [Cited by in Crossref: 109] [Cited by in F6Publishing: 20] [Article Influence: 4.4] [Reference Citation Analysis]
62 Oshiro Y, Fukuda T, Tsuneyoshi M. Atypical fibroxanthoma versus benign and malignant fibrous histiocytoma. A comparative study of their proliferative activity using MIB-1, DNA flow cytometry, and p53 immunostaining. Cancer 1995;75:1128-34. [DOI: 10.1002/1097-0142(19950301)75:5<1128::aid-cncr2820750512>3.0.co;2-h] [Cited by in Crossref: 30] [Cited by in F6Publishing: 2] [Article Influence: 1.2] [Reference Citation Analysis]
63 Kim CH, Dancer JY, Coffey D, Zhai QJ, Reardon M, Ayala AG, Ro JY. Clinicopathologic study of 24 patients with primary cardiac sarcomas: a 10-year single institution experience. Human Pathology 2008;39:933-8. [DOI: 10.1016/j.humpath.2007.12.018] [Cited by in Crossref: 63] [Cited by in F6Publishing: 33] [Article Influence: 4.8] [Reference Citation Analysis]
64 Teng H, Xinghai Y, Wei H, Huang Q, Xiao J, Zhang C. Malignant fibrous histiocytoma of the spine: a series of 13 clinical case reports and review of 17 published cases. Spine (Phila Pa 1976) 2011;36:E1453-62. [PMID: 21343863 DOI: 10.1097/BRS.0b013e318203e292] [Cited by in Crossref: 12] [Cited by in F6Publishing: 1] [Article Influence: 1.3] [Reference Citation Analysis]
65 Qian X. Soft Tissue. Cytology. Elsevier; 2009. pp. 451-94. [DOI: 10.1016/b978-1-4160-5329-3.00016-5] [Cited by in Crossref: 4] [Article Influence: 0.3] [Reference Citation Analysis]
66 Agaimy A, Stoehr R, Hornung A, Popp J, Erdmann M, Heinzerling L, Hartmann A. Dedifferentiated and Undifferentiated Melanomas: Report of 35 New Cases With Literature Review and Proposal of Diagnostic Criteria. Am J Surg Pathol 2021;45:240-54. [PMID: 33428337 DOI: 10.1097/PAS.0000000000001645] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
67 Kashima T, Halai D, Ye H, Hing SN, Delaney D, Pollock R, O'Donnell P, Tirabosco R, Flanagan AM. Sensitivity of MDM2 amplification and unexpected multiple faint alphoid 12 (alpha 12 satellite sequences) signals in atypical lipomatous tumor. Mod Pathol 2012;25:1384-96. [PMID: 22699518 DOI: 10.1038/modpathol.2012.90] [Cited by in Crossref: 35] [Cited by in F6Publishing: 28] [Article Influence: 3.9] [Reference Citation Analysis]
68 Agaimy A, Gaumann A, Schroeder J, Dietmaier W, Hartmann A, Hofstaedter F, Wünsch PH, Mentzel T. Primary and metastatic high-grade pleomorphic sarcoma/malignant fibrous histiocytoma of the gastrointestinal tract: an approach to the differential diagnosis in a series of five cases with emphasis on myofibroblastic differentiation. Virchows Arch 2007;451:949-57. [DOI: 10.1007/s00428-007-0495-3] [Cited by in Crossref: 22] [Cited by in F6Publishing: 8] [Article Influence: 1.6] [Reference Citation Analysis]
69 Fletcher CD, Gustafson P, Rydholm A, Willén H, Åkerman M. Clinicopathologic Re-Evaluation of 100 Malignant Fibrous Histiocytomas: Prognostic Relevance of Subclassification. JCO 2001;19:3045-50. [DOI: 10.1200/jco.2001.19.12.3045] [Cited by in Crossref: 245] [Cited by in F6Publishing: 47] [Article Influence: 12.3] [Reference Citation Analysis]
70 Brooks J. The spectrum of fibrohistiocytic tumours with special emphasis on malignant fibrous histiocytoma. Current Diagnostic Pathology 1994;1:3-11. [DOI: 10.1016/s0968-6053(06)80003-7] [Cited by in Crossref: 5] [Article Influence: 0.2] [Reference Citation Analysis]
71 Folpe AL. Fibrosarcoma: a review and update. Histopathology 2014;64:12-25. [PMID: 24266941 DOI: 10.1111/his.12282] [Cited by in Crossref: 51] [Cited by in F6Publishing: 26] [Article Influence: 6.4] [Reference Citation Analysis]
72 Hartel PH, Bratthauer G, Hartel JV, Fanburg-smith JC. Primary malignant fibrous histiocytoma (myxofibrosarcoma/pleomorphic sarcoma not otherwise specified) of the breast: clinicopathologic study of 19 cases. Annals of Diagnostic Pathology 2011;15:407-13. [DOI: 10.1016/j.anndiagpath.2011.05.007] [Cited by in Crossref: 22] [Cited by in F6Publishing: 7] [Article Influence: 2.2] [Reference Citation Analysis]
73 Montgomery E, Fisher C. Myofibroblastic differentiation in malignant fibrous histiocytoma (pleomorphic myofibrosarcoma): a clinicopathological study: Myofibroblastic differentiation in MFH. Histopathology 2001;38:499-509. [DOI: 10.1046/j.1365-2559.2001.01152.x] [Cited by in Crossref: 57] [Cited by in F6Publishing: 37] [Article Influence: 2.9] [Reference Citation Analysis]
74 Engellau J, Anderson H, Rydholm A, Bauer HC, Hall KS, Gustafson P, Akerman M, Meis-Kindblom J, Alvegård TA, Nilbert M; Scandinavian Sarcoma Group. Time dependence of prognostic factors for patients with soft tissue sarcoma: a Scandinavian Sarcoma Group Study of 338 malignant fibrous histiocytomas. Cancer 2004;100:2233-9. [PMID: 15139069 DOI: 10.1002/cncr.20254] [Cited by in Crossref: 30] [Cited by in F6Publishing: 20] [Article Influence: 1.8] [Reference Citation Analysis]
75 Adler C. Bone Tumors. Bone Diseases. Berlin: Springer Berlin Heidelberg; 2000. pp. 207-421. [DOI: 10.1007/978-3-662-04088-1_11] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
76 Perry DA, Schultz LR, Dehner LP. Giant cell fibroblastoma with dermatofibrosarcoma protuberans-like transformation. J Cutan Pathol 1993;20:451-4. [DOI: 10.1111/j.1600-0560.1993.tb00670.x] [Cited by in Crossref: 30] [Cited by in F6Publishing: 15] [Article Influence: 1.1] [Reference Citation Analysis]
77 Guerrero S, Figueras A, Casanova I, Farré L, Lloveras B, Capellà G, Trias M, Mangues R. Codon 12 and codon 13 mutations at the K-ras gene induce different soft tissue sarcoma types in nude mice. FASEB J 2002;16:1642-4. [PMID: 12207005 DOI: 10.1096/fj.02-0050fje] [Cited by in Crossref: 25] [Cited by in F6Publishing: 25] [Article Influence: 1.3] [Reference Citation Analysis]
78 Diaz-cascajo C, Bernd R, Teresa M, Fernandez-figueras, Borghi S. Malignant Fibrous Histiocytoma of the Skin With Marked Inflammatory Infiltrate:: A Sarcoma Mimicking Malignant Lymphoma. The American Journal of Dermatopathology 2002;24:251-6. [DOI: 10.1097/00000372-200206000-00011] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
79 Ziemer M, Jäger IM, Dippel E. Atypisches Fibroxanthom und pleomorphes dermales Sarkom. Hautarzt 2019;70:661-9. [DOI: 10.1007/s00105-019-04471-8] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
80 Wilk1 M, Nilles2 M, Zelger3 B. Atypisches Fibroxanthom - eine nicht-"histiozytare" Neoplasie. . Atypical fibroxanthoma - a non-histiocytic neoplasm. H&G Zeitschrift Hautkrankheiten 2002;77:289-93. [DOI: 10.1046/j.1439-0353.2002.02095.x] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
81 Rapidis AD, Andressakis DD, Lagogiannis GA, Douzinas EE. Malignant fibrous histiocytoma of the tongue: Review of the literature and report of a case. Journal of Oral and Maxillofacial Surgery 2005;63:546-50. [DOI: 10.1016/j.joms.2004.06.061] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 0.9] [Reference Citation Analysis]
82 Meister P. Malignant Fibrous Histiocytoma: Histomorphological Pattern or Tumour Type. Pathology - Research and Practice 1996;192:877-81. [DOI: 10.1016/s0344-0338(96)80066-5] [Cited by in Crossref: 12] [Article Influence: 0.5] [Reference Citation Analysis]
83 Mentzel T, Dry S, Katenkamp D, Fletcher CD. Low-Grade Myofibroblastic Sarcoma: Analysis of 18 Cases in the Spectrum of Myofibroblastic Tumors. The American Journal of Surgical Pathology 1998;22:1228-38. [DOI: 10.1097/00000478-199810000-00008] [Cited by in Crossref: 195] [Cited by in F6Publishing: 88] [Article Influence: 8.5] [Reference Citation Analysis]
84 Folpe AL. “Hey! Whatever happened to hemangiopericytoma and fibrosarcoma?” An update on selected conceptual advances in soft tissue pathology which have occurred over the past 50 years. Human Pathology 2020;95:113-36. [DOI: 10.1016/j.humpath.2019.10.001] [Cited by in Crossref: 7] [Cited by in F6Publishing: 1] [Article Influence: 7.0] [Reference Citation Analysis]
85 Lee K, Song JS, Kim JE, Kim W, Song SY, Lee MH, Chung HW, Cho KJ, Lee JS, Ahn JH. The clinical outcomes of undifferentiated pleomorphic sarcoma (UPS): A single-centre experience of two decades with the assessment of PD-L1 expressions. Eur J Surg Oncol 2020;46:1287-93. [PMID: 32127249 DOI: 10.1016/j.ejso.2020.02.029] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 5.0] [Reference Citation Analysis]
86 Klijanienko J, Pierron G, Sastre-garau X, Theocharis S. Value of combined cytology and molecular information in the diagnosis of soft tissue tumors: Diagnosis of Soft Tissue Tumors. Cancer Cytopathology 2015;123:141-51. [DOI: 10.1002/cncy.21496] [Cited by in Crossref: 12] [Cited by in F6Publishing: 6] [Article Influence: 1.7] [Reference Citation Analysis]
87 Cipriani NA, Kurzawa P, Ahmad RA, Deshpande V, Hornicek FJ, Mullen JT, Nielsen GP. Prognostic value of myogenic differentiation in undifferentiated pleomorphic sarcomas of soft tissue. Human Pathology 2014;45:1504-8. [DOI: 10.1016/j.humpath.2014.03.002] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 1.1] [Reference Citation Analysis]
88 Berardo MD, Powers CN, Wakely PE, Almeida MO, Frable WJ. Fine-needle aspiration cytopathology of malignant fibrous histiocytoma. Cancer 1997;81:228-37. [DOI: 10.1002/(sici)1097-0142(19970825)81:4<228::aid-cncr5>3.0.co;2-l] [Cited by in Crossref: 31] [Article Influence: 1.3] [Reference Citation Analysis]
89 Rehg JE, Ward JM. Morphological and Immunohistochemical Characterization of Sarcomatous Tumors in Wild-Type and Genetically Engineered Mice. Vet Pathol 2012;49:206-17. [DOI: 10.1177/0300985811429813] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
90 Erlandson RA, Antonescu CR. The Rise and Fall of Malignant Fibrous Histiocytoma. Ultrastructural Pathology 2009;28:283-9. [DOI: 10.1080/019131290882150] [Cited by in Crossref: 33] [Cited by in F6Publishing: 14] [Article Influence: 2.8] [Reference Citation Analysis]
91 Wade TR, Finan MC, Stahr BJ, White WL, Troy JL. Self Assessment*. J Cutan Pathol 1993;20:513-513. [DOI: 10.1111/j.1600-0560.1993.tb00680.x] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
92 Romeo S, Bovée JVMG, Kroon HM, Tirabosco R, Natali C, Zanatta L, Sciot R, Mertens F, Athanasou N, Alberghini M, Szuhai K, Hogendoorn PCW, Dei Tos AP. Malignant fibrous histiocytoma and fibrosarcoma of bone: a re-assessment in the light of currently employed morphological, immunohistochemical and molecular approaches. Virchows Arch 2012;461:561-70. [DOI: 10.1007/s00428-012-1306-z] [Cited by in Crossref: 54] [Cited by in F6Publishing: 33] [Article Influence: 6.0] [Reference Citation Analysis]
93 Oshiro Y, Shiratsuchi H, Oda Y, Toyoshima S, Tsuneyoshi M. Rhabdoid Features in Leiomyosarcoma of Soft Tissue: With Special Reference to Aggressive Behavior. Mod Pathol 2000;13:1211-8. [DOI: 10.1038/modpathol.3880225] [Cited by in Crossref: 37] [Cited by in F6Publishing: 27] [Article Influence: 1.8] [Reference Citation Analysis]
94 Zelger BG, Steiner H, Wambacher B, Zelger B. Malignant Melanomas Simulating Various Types of Soft Tissue Tumors: . Dermatologic Surgery 1997;23:1047-54. [DOI: 10.1111/j.1524-4725.1997.tb00446.x] [Cited by in Crossref: 18] [Cited by in F6Publishing: 11] [Article Influence: 0.8] [Reference Citation Analysis]
95 van Unnik J. Classification and Grading of Soft-Tissue Sarcomas. Hematology/Oncology Clinics of North America 1995;9:677-700. [DOI: 10.1016/s0889-8588(18)30091-1] [Cited by in Crossref: 10] [Article Influence: 0.4] [Reference Citation Analysis]
96 Yamate J, Tajima M, Shibuya K, Kuwamura M, Kotani T, Sakuma S. Phenotypic modulation in cisplatin-resistant cloned cells derived from transplantable rat malignant fibrous histiocytoma. Pathology International 1996;46:557-67. [DOI: 10.1111/j.1440-1827.1996.tb03654.x] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 0.2] [Reference Citation Analysis]
97 Schürch W, Bégin LR, Seemayer TA, Lagacé R, Boivin J, Lamoureux C, Bluteau P, Piché J, Gabbiani G. Pleomorphic Soft Tissue Myogenic Sarcomas of Adulthood: A Reappraisal in the Mid-1990s. The American Journal of Surgical Pathology 1996;20:131-47. [DOI: 10.1097/00000478-199602000-00001] [Cited by in Crossref: 60] [Cited by in F6Publishing: 40] [Article Influence: 2.4] [Reference Citation Analysis]
98 Goldblum JR. An approach to pleomorphic sarcomas: can we subclassify, and does it matter? Mod Pathol 2014;27:S39-46. [DOI: 10.1038/modpathol.2013.174] [Cited by in Crossref: 58] [Cited by in F6Publishing: 27] [Article Influence: 8.3] [Reference Citation Analysis]
99 Larramendy ML, Gentile M, Soloneski S, Knuutila S, Böhling T. Does comparative genomic hybridization reveal distinct differences in DNA copy number sequence patterns between leiomyosarcoma and malignant fibrous histiocytoma? Cancer Genet Cytogenet 2008;187:1-11. [PMID: 18992634 DOI: 10.1016/j.cancergencyto.2008.06.005] [Cited by in Crossref: 21] [Cited by in F6Publishing: 17] [Article Influence: 1.6] [Reference Citation Analysis]
100 Perez-montiel MD, Frankel WL, Suster S. Neuroendocrine Carcinomas of the Pancreas With `Rhabdoidʼ Features: . The American Journal of Surgical Pathology 2003;27:642-9. [DOI: 10.1097/00000478-200305000-00007] [Cited by in Crossref: 36] [Cited by in F6Publishing: 19] [Article Influence: 2.0] [Reference Citation Analysis]
101 Matsuo T, Shay JW, Wright WE, Hiyama E, Shimose S, Kubo T, Sugita T, Yasunaga Y, Ochi M. Telomere-maintenance mechanisms in soft-tissue malignant fibrous histiocytomas. J Bone Joint Surg Am 2009;91:928-37. [PMID: 19339578 DOI: 10.2106/JBJS.G.01390] [Cited by in Crossref: 16] [Cited by in F6Publishing: 11] [Article Influence: 1.3] [Reference Citation Analysis]
102 Fujimura T, Okuyama R, Terui T, Okuno K, Masu A, Masu T, Chiba S, Kunii T, Tagami H, Aiba S. Myxofibrosarcoma (myxoid malignant fibrous histiocytoma) showing cutaneous presentation: report of two cases. J Cutan Pathol 2005;32:512-5. [DOI: 10.1111/j.0303-6987.2005.00368.x] [Cited by in Crossref: 27] [Cited by in F6Publishing: 14] [Article Influence: 1.7] [Reference Citation Analysis]
103 Nakayama R, Nemoto T, Takahashi H, Ohta T, Kawai A, Seki K, Yoshida T, Toyama Y, Ichikawa H, Hasegawa T. Gene expression analysis of soft tissue sarcomas: characterization and reclassification of malignant fibrous histiocytoma. Mod Pathol 2007;20:749-59. [PMID: 17464315 DOI: 10.1038/modpathol.3800794] [Cited by in Crossref: 133] [Cited by in F6Publishing: 85] [Article Influence: 9.5] [Reference Citation Analysis]
104 Franchi A, Santucci M. Tenascin Expression in Cutaneous Fibrohistiocytic Tumors: Immunohistochemical Investigation of 24 Cases. The American Journal of Dermatopathology 1996;18:454-9. [DOI: 10.1097/00000372-199610000-00002] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 0.3] [Reference Citation Analysis]
105 Alfredo E, de Pádua JM, Vicentini EL, Marchesan MA, Comelli Lia RC, da Cruz Perez DE, Silva-Sousa YT. Oral undifferentiated high-grade pleomorphic sarcoma: report of a case. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2008;105:e37-40. [PMID: 18155600 DOI: 10.1016/j.tripleo.2007.07.023] [Cited by in Crossref: 9] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
106 Liles JS, Tzeng CW, Short JJ, Kulesza P, Heslin MJ. Retroperitoneal and intra-abdominal sarcoma. Curr Probl Surg. 2009;46:445-503. [PMID: 19414097 DOI: 10.1067/j.cpsurg.2009.01.004] [Cited by in Crossref: 41] [Cited by in F6Publishing: 23] [Article Influence: 3.4] [Reference Citation Analysis]
107 Marcet S. Atypical fibroxanthoma/malignant fibrous histiocytoma. Dermatol Ther. 2008;21:424-427. [PMID: 19076618 DOI: 10.1111/j.1529-8019.2008.00241.x] [Cited by in Crossref: 22] [Cited by in F6Publishing: 12] [Article Influence: 1.8] [Reference Citation Analysis]
108 Choong PFM, Pritchard DJ, Rock MG, Sim FH, Frassica FJ. Survival after pulmonary metastasectomy in soft tissue sarcoma: Prognostic factors in 214 patients. Acta Orthopaedica Scandinavica 2009;66:561-8. [DOI: 10.3109/17453679509002316] [Cited by in Crossref: 74] [Cited by in F6Publishing: 52] [Article Influence: 6.2] [Reference Citation Analysis]
109 Fletcher CDM. Immunohistochemistry in Diagnosis of Soft Tissue Sarcomas and New Techniques in Soft Tissue Tumour Pathology. In: Bamberg M, Hoffmann W, Hossfeld DK, editors. Soft Tissue Sarcomas in Adults. Berlin: Springer Berlin Heidelberg; 1995. pp. 17-24. [DOI: 10.1007/978-3-642-78768-3_3] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.0] [Reference Citation Analysis]
110 Fisher C. Current aspects of the pathology of soft tissue sarcomas. Seminars in Radiation Oncology 1999;9:315-27. [DOI: 10.1016/s1053-4296(99)80026-5] [Cited by in Crossref: 6] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
111 Ramachandra S, Hollowood K, Bisceglia M, Fletcher CD. Inflammatory pseudotumour of soft tissues: a clinicopathological and immunohistochemical analysis of 18 cases. Histopathology 1995;27:313-23. [PMID: 8847061 DOI: 10.1111/j.1365-2559.1995.tb01521.x] [Cited by in Crossref: 84] [Cited by in F6Publishing: 55] [Article Influence: 3.4] [Reference Citation Analysis]
112 Tos APD. Classification of pleomorphic sarcomas: where are we now? Histopathology 2006;48:51-62. [DOI: 10.1111/j.1365-2559.2005.02289.x] [Cited by in Crossref: 105] [Cited by in F6Publishing: 45] [Article Influence: 7.0] [Reference Citation Analysis]
113 Zelger B. Connective tissue tumors. Recent Results Cancer Res 2002;160:343-50. [PMID: 12079232 DOI: 10.1007/978-3-642-59410-6_39] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
114 Chow LT, Wong SK. Primary osseous inflammatory malignant fibrous histiocytoma masquerading as chronic osteomyelitis. Orthopedics 2014;37:e940-5. [PMID: 25275985 DOI: 10.3928/01477447-20140924-92] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
115 Molenaar WM, Berg EVD, Veth RPH, Dijkhuizen T, De Vries EGE. Tumor progression in a giant cell type malignant fibrous histiocytoma of bone: Clinical, radiologic, histologic, and cytogenetic evidence. Genes Chromosom Cancer 1994;10:66-70. [DOI: 10.1002/gcc.2870100111] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 0.3] [Reference Citation Analysis]
116 Fernandez-Flores A, Varela-Vazquez A, Mayan MD, Fonseca E. Expression of connexin 43 by atypical fibroxanthoma. J Cutan Pathol 2021;48:247-54. [PMID: 32851695 DOI: 10.1111/cup.13856] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
117 Steele CD, Pillay N. The genomics of undifferentiated sarcoma of soft tissue: Progress, challenges and opportunities. Semin Cancer Biol 2020;61:42-55. [PMID: 31866474 DOI: 10.1016/j.semcancer.2019.11.009] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
118 Tran TA, Muller S, Chaudahri PJ, Carlson JA. Cutaneous carcinosarcoma: adnexal vs. epidermal types define high- and low-risk tumors. Results of a meta-analysis. J Cutan Pathol 2005;32:2-11. [PMID: 15660649 DOI: 10.1111/j.0303-6987.2005.00260.x] [Cited by in Crossref: 86] [Cited by in F6Publishing: 55] [Article Influence: 5.4] [Reference Citation Analysis]
119 Barr RJ, Alpern KS, Santa Cruz DJ, Fretzin DF. Clear cell basal cell carcinoma: An unusual degenerative variant. J Cutan Pathol 1993;20:308-16. [DOI: 10.1111/j.1600-0560.1993.tb01267.x] [Cited by in Crossref: 48] [Cited by in F6Publishing: 25] [Article Influence: 1.7] [Reference Citation Analysis]
120 Mentzel T, Calonje E, Wadden C, Camplejohn RS, Beham A, Smith MA, Fletcher CD. Myxofibrosarcoma. Clinicopathologic analysis of 75 cases with emphasis on the low-grade variant. Am J Surg Pathol. 1996;20:391-405. [PMID: 8604805 DOI: 10.1097/00000478-199604000-00001] [Cited by in Crossref: 364] [Cited by in F6Publishing: 231] [Article Influence: 14.6] [Reference Citation Analysis]
121 Mechtersheimer G, Renner M, Penzel R, Schirmacher P. Pleomorphe High-grade-Sarkome der Weichgewebe: Ist die Subklassifikation zeitgemäß? Pathologe 2011;32:47-56. [DOI: 10.1007/s00292-010-1400-4] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
122 Parham DM. Pathologic classification of rhabdomyosarcomas and correlations with molecular studies. Mod Pathol 2001;14:506-14. [PMID: 11353062 DOI: 10.1038/modpathol.3880339] [Cited by in Crossref: 149] [Cited by in F6Publishing: 77] [Article Influence: 7.5] [Reference Citation Analysis]
123 Anderson WJ, Jo VY. Pleomorphic liposarcoma: Updates and current differential diagnosis. Semin Diagn Pathol 2019;36:122-8. [PMID: 30852046 DOI: 10.1053/j.semdp.2019.02.007] [Cited by in Crossref: 15] [Cited by in F6Publishing: 10] [Article Influence: 7.5] [Reference Citation Analysis]
124 Toulmonde M, Lucchesi C, Verbeke S, Crombe A, Adam J, Geneste D, Chaire V, Laroche-Clary A, Perret R, Bertucci F, Bertolo F, Bianchini L, Dadone-Montaudie B, Hembrough T, Sweet S, Kim YJ, Cecchi F, Le Loarer F, Italiano A. High throughput profiling of undifferentiated pleomorphic sarcomas identifies two main subgroups with distinct immune profile, clinical outcome and sensitivity to targeted therapies. EBioMedicine 2020;62:103131. [PMID: 33254023 DOI: 10.1016/j.ebiom.2020.103131] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
125 Nakatani T, Marui T, Yamamoto T, Kurosaka M, Akisue T, Matsumoto K. Establishment and characterization of cell line TNMY1 derived from human malignant fibrous histiocytoma. Pathol Int 2001;51:595-602. [DOI: 10.1046/j.1440-1827.2001.01253.x] [Cited by in Crossref: 15] [Cited by in F6Publishing: 9] [Article Influence: 0.8] [Reference Citation Analysis]
126 Singer S, Demetri GD, Baldini EH, Fletcher CD. Management of soft-tissue sarcomas: an overview and update. The Lancet Oncology 2000;1:75-85. [DOI: 10.1016/s1470-2045(00)00016-4] [Cited by in Crossref: 117] [Cited by in F6Publishing: 45] [Article Influence: 5.6] [Reference Citation Analysis]
127 Fukunaga M, Ushigome S. Proximal-type epithelioid sarcoma in the pelvic soft tissues. APMIS 1999;107:283-8. [DOI: 10.1111/j.1699-0463.1999.tb01555.x] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 0.4] [Reference Citation Analysis]
128 Hartel PH, Jackson J, Ducatman BS, Zhang P. CD99 immunoreactivity in atypical fibroxanthoma and pleomorphic malignant fibrous histiocytoma: a useful diagnostic marker. J Cutan Pathol 2006;33 Suppl 2:24-8. [PMID: 16972949 DOI: 10.1111/j.1600-0560.2006.00492.x] [Cited by in Crossref: 48] [Cited by in F6Publishing: 30] [Article Influence: 3.4] [Reference Citation Analysis]
129 Rapidis AD. Sarcomas of the head and neck in adult patients: current concepts and future perspectives. Expert Review of Anticancer Therapy 2014;8:1271-97. [DOI: 10.1586/14737140.8.8.1271] [Cited by in Crossref: 11] [Cited by in F6Publishing: 5] [Article Influence: 1.6] [Reference Citation Analysis]
130 Choong PFM, Åkerman M, Willén H, Andersson C, Gustafson P, Alvegård T, Rydholm A. Expression of proliferating cell nuclear antigen (PCNA) and Ki-67 in soft tissue sarcoma. Is prognostic significance histotype-specific? APMIS 1995;103:797-805. [DOI: 10.1111/j.1699-0463.1995.tb01437.x] [Cited by in Crossref: 25] [Cited by in F6Publishing: 21] [Article Influence: 1.0] [Reference Citation Analysis]
131 Mcgee RS, Ward WG, Kilpatrick SE. Malignant peripheral nerve sheath tumor: A fine-needle aspiration biopsy study. Diagn Cytopathol 1997;17:298-305. [DOI: 10.1002/(sici)1097-0339(199710)17:4<298::aid-dc12>3.0.co;2-j] [Cited by in Crossref: 26] [Article Influence: 1.1] [Reference Citation Analysis]
132 Hisaoka M, Wei-qi S, Jian W, Morio T, Hashimoto H. Specific but Variable Expression of h-Caldesmon in Leiomyosarcomas: An Immunohistochemical Reassessment of a Novel Myogenic Marker. Applied Immunohistochemistry & Molecular Morphology 2001;9:302-8. [DOI: 10.1097/00129039-200112000-00003] [Cited by in Crossref: 15] [Cited by in F6Publishing: 11] [Article Influence: 0.8] [Reference Citation Analysis]
133 Hornick JL, Bosenberg MW, Mentzel T, Mcmenamin ME, Oliveira AM, Fletcher CDM. Pleomorphic Liposarcoma: Clinicopathologic Analysis of 57 Cases. The American Journal of Surgical Pathology 2004;28:1257-67. [DOI: 10.1097/01.pas.0000135524.73447.4a] [Cited by in Crossref: 168] [Cited by in F6Publishing: 93] [Article Influence: 9.9] [Reference Citation Analysis]
134 Beer TW, Drury P, Heenan PJ. Atypical Fibroxanthoma: A Histological and Immunohistochemical Review of 171 Cases. The American Journal of Dermatopathology 2010;32:533-40. [DOI: 10.1097/dad.0b013e3181c80b97] [Cited by in Crossref: 80] [Cited by in F6Publishing: 5] [Article Influence: 7.3] [Reference Citation Analysis]
135 Miyajima K, Oda Y, Tamiya S, Shimizu K, Hachitanda Y, Tsuneyoshi M. Cytogenetic and clinicopathological analysis of soft-tissue leiomyosarcomas. Pathol Int 2003;53:163-8. [DOI: 10.1046/j.1440-1827.2003.01449.x] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 0.6] [Reference Citation Analysis]
136 Zelger B. Pigmented Atypical Fibroxanthoma, a Dermatofibroma Variant?: . The American Journal of Dermatopathology 2004;26:84-6. [DOI: 10.1097/00000372-200402000-00018] [Cited by in Crossref: 9] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
137 Katoh M, Shigematsu H. Leiomyosarcoma of the heart and its pulmonary metastasis, both with prominent osteoclast‐like multinucleated giant cells expressing tartrate‐resistant acid phosphatase activity. Pathology International 2002;49:74-8. [DOI: 10.1046/j.1440-1827.1999.00817.x] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
138 Mentzel T, Requena L, Brenn T. Atypical Fibroxanthoma Revisited. Surg Pathol Clin 2017;10:319-35. [PMID: 28477883 DOI: 10.1016/j.path.2017.01.007] [Cited by in Crossref: 25] [Cited by in F6Publishing: 15] [Article Influence: 6.3] [Reference Citation Analysis]
139 Zelger BG, Soyer HP, Zelger B. Giant Cell Atypical Fibroxanthoma: Does it Really Exist?: . The American Journal of Dermatopathology 1999;21:108-9. [DOI: 10.1097/00000372-199902000-00087] [Cited by in Crossref: 17] [Cited by in F6Publishing: 13] [Article Influence: 0.8] [Reference Citation Analysis]
140 Clarke LE. Fibrous and fibrohistiocytic neoplasms: an update. Dermatol Clin 2012;30:643-56, vi. [PMID: 23021051 DOI: 10.1016/j.det.2012.06.005] [Cited by in Crossref: 12] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
141 Winchester D, Lehman J, Tello T, Chimato N, Hocker T, Kim S, Chang J, Markey J, Yom SS, Ryan W, Mully T, Hodge D, Otley C, Arron ST. Undifferentiated pleomorphic sarcoma: Factors predictive of adverse outcomes. Journal of the American Academy of Dermatology 2018;79:853-9. [DOI: 10.1016/j.jaad.2018.05.022] [Cited by in Crossref: 18] [Cited by in F6Publishing: 12] [Article Influence: 6.0] [Reference Citation Analysis]
142 Wick MR, Swanson PE, Ritter JH, Fitzgibbon JF. The immunohistology of cutaneous neoplasia:. A practical perspective. J Cutan Pathol 1993;20:481-97. [DOI: 10.1111/j.1600-0560.1993.tb00676.x] [Cited by in Crossref: 25] [Cited by in F6Publishing: 17] [Article Influence: 0.9] [Reference Citation Analysis]
143 Hatano H, Tokunaga K, Ogose A, Imaizumi S, Hayami T, Yamagiwa H, Hotta T, Endo N, Takahashi HE, Naito M. Origin of histiocyte-like cells and multinucleated giant cells in malignant fibrous histiocytoma: neoplastic or reactive? Pathol Int 1999;49:14-22. [PMID: 10227720 DOI: 10.1046/j.1440-1827.1999.00819.x] [Cited by in Crossref: 15] [Cited by in F6Publishing: 9] [Article Influence: 0.7] [Reference Citation Analysis]
144 Fleury RN, Damante JH, Soares CT, Sant’ana E, Júnior EJFM, Moreira CR. Malignant fibrous histiocytoma (undifferentiated high-grade pleomorphic sarcoma) occurring in tuberous sclerosis: a case report. Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontology 2007;103:e54-9. [DOI: 10.1016/j.tripleo.2006.05.014] [Cited by in Crossref: 10] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
145 Kerlin RL, Hendrick MJ. Malignant fibrous histiocytoma and malignant histiocytosis in the dog--convergent or divergent phenotypic differentiation? Vet Pathol 1996;33:713-6. [PMID: 8952034 DOI: 10.1177/030098589603300614] [Cited by in Crossref: 35] [Cited by in F6Publishing: 18] [Article Influence: 1.5] [Reference Citation Analysis]
146 Mankin HJ, Hornicek FJ. Diagnosis, Classification, and Management of Soft Tissue Sarcomas. Cancer Control 2017;12:5-21. [DOI: 10.1177/107327480501200102] [Cited by in Crossref: 64] [Cited by in F6Publishing: 35] [Article Influence: 16.0] [Reference Citation Analysis]
147 Eilber FC, Tap WD, Nelson SD, Eckardt JJ, Eilber FR. Advances in chemotherapy for patients with extremity soft tissue sarcoma. Orthop Clin North Am 2006;37:15-22. [PMID: 16311108 DOI: 10.1016/j.ocl.2005.07.001] [Cited by in Crossref: 18] [Cited by in F6Publishing: 7] [Article Influence: 1.2] [Reference Citation Analysis]
148 Alaggio R, Collini P, Randall RL, Barnette P, Million L, Coffin CM. Undifferentiated High-Grade Pleomorphic Sarcomas in Children: A Clinicopathologic Study of 10 Cases and Review of Literature. Pediatr Dev Pathol 2010;13:209-17. [DOI: 10.2350/09-07-0673-oa.1] [Cited by in Crossref: 17] [Cited by in F6Publishing: 2] [Article Influence: 1.9] [Reference Citation Analysis]
149 Tomita Y, Kuratsu S, Naka N, Uchida A, Ono K, Ohsawa M, Aozasa K. A staging system for soft-tissue sarcoma and its evaluation in relation to treatment. Int J Cancer 1994;58:168-73. [DOI: 10.1002/ijc.2910580204] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 0.6] [Reference Citation Analysis]
150 Roncaroli F, Eusebi V. Rhabdomyoblastic differentiation in a leiomyosarcoma of the retroperitoneum. Human Pathology 1996;27:310-3. [DOI: 10.1016/s0046-8177(96)90075-1] [Cited by in Crossref: 12] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
151 Moran CA, Koss MN, Suster S, Perino G, Kaneko M. Malignant smooth muscle tumors presenting as mediastinal soft tissue masses. A clinicopathologic study of 10 cases. Cancer 1994;74:2251-60. [DOI: 10.1002/1097-0142(19941015)74:8<2251::aid-cncr2820740808>3.0.co;2-4] [Cited by in Crossref: 63] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]
152 Chorneyko K. The Ultrastructure of Liposarcomas with Attention to "Dedifferentiation". Ultrastructural Pathology 2009;21:545-57. [DOI: 10.3109/01913129709016371] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
153 Smith DM, Mahmoud HH, Jenkins JJ, Rao B, Hopkins KP, Parham DM. Myofibrosarcoma of the Head and Neck in Children. Pediatric Pathology & Laboratory Medicine 2009;15:403-18. [DOI: 10.3109/15513819509026976] [Cited by in Crossref: 55] [Cited by in F6Publishing: 34] [Article Influence: 4.6] [Reference Citation Analysis]
154 Nishio J, Iwasaki H, Sakashita N, Haraoka S, Isayama T, Naito M, Miyayama H, Yamashita Y, Kikuchi M. Undifferentiated (embryonal) sarcoma of the liver in middle-aged adults: smooth muscle differentiation determined by immunohistochemistry and electron microscopy. Hum Pathol. 2003;34:246-252. [PMID: 12673559 DOI: 10.1053/hupa.2003.44] [Cited by in Crossref: 38] [Cited by in F6Publishing: 23] [Article Influence: 2.1] [Reference Citation Analysis]
155 Erlandson RA, Woodruff JM. Role of electron microscopy in the evaluation of soft tissue neoplasms, with emphasis on spindle cell and pleomorphic tumors. Hum Pathol 1998;29:1372-81. [PMID: 9865822 DOI: 10.1016/s0046-8177(98)90005-3] [Cited by in Crossref: 43] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
156 Wu Y, Liu X, Lv Y, Li Z. Malignant fibrous histiocytoma of the floor of mouth: a case report and review of the literature. J Stomatol Oral Maxillofac Surg 2021:S2468-7855(21)00143-9. [PMID: 34224923 DOI: 10.1016/j.jormas.2021.06.017] [Reference Citation Analysis]
157 Nascimento AF, Raut CP. Diagnosis and management of pleomorphic sarcomas (so-called “MFH”) in adults. J Surg Oncol 2008;97:330-9. [DOI: 10.1002/jso.20972] [Cited by in Crossref: 74] [Cited by in F6Publishing: 34] [Article Influence: 5.7] [Reference Citation Analysis]
158 Liegl-atzwanger B, Hofmann G, Leithner A, Beham A. Undifferentiated high-grade pleomorphic sarcoma (UHPS): Diagnostic criteria, differential diagnosis, and treatment. An attempt to erasure the misnomer "MFH". Eur Surg 2009;41:143-9. [DOI: 10.1007/s10353-009-0474-9] [Cited by in Crossref: 11] [Cited by in F6Publishing: 6] [Article Influence: 0.9] [Reference Citation Analysis]
159 Gru AA, Santa Cruz DJ. Atypical fibroxanthoma: a selective review. Seminars in Diagnostic Pathology 2013;30:4-12. [DOI: 10.1053/j.semdp.2012.01.001] [Cited by in Crossref: 31] [Cited by in F6Publishing: 11] [Article Influence: 3.9] [Reference Citation Analysis]
160 Nikitin AYu, Rajewsky MF, Pozharisski KM. Development of malignant fibrous histiocytoma induced by 7,12-dimethylbenz[a]anthracene in the rat: characterization of early atypical cells. Virchows Arch B Cell Pathol Incl Mol Pathol 1993;64:151-9. [PMID: 7902172 DOI: 10.1007/BF02915108] [Cited by in Crossref: 9] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
161 Hoffman A, Lazar AJ, Pollock RE, Lev D. New frontiers in the treatment of liposarcoma, a therapeutically resistant malignant cohort. Drug Resist Updat 2011;14:52-66. [PMID: 21169051 DOI: 10.1016/j.drup.2010.11.001] [Cited by in Crossref: 36] [Cited by in F6Publishing: 26] [Article Influence: 3.3] [Reference Citation Analysis]
162 Lewin J, Garg S, Lau BY, Dickson BC, Traub F, Gokgoz N, Griffin AM, Ferguson PC, Andrulis IL, Sim HW, Kamel-Reid S, Stockley TL, Siu LL, Wunder JS, Razak ARA. Identifying actionable variants using next generation sequencing in patients with a historical diagnosis of undifferentiated pleomorphic sarcoma. Int J Cancer 2018;142:57-65. [PMID: 28891048 DOI: 10.1002/ijc.31039] [Cited by in Crossref: 15] [Cited by in F6Publishing: 7] [Article Influence: 3.8] [Reference Citation Analysis]
163 Miettinen M. Immunohistochemistry of Soft Tissue Tumors: A Review. Journal of Histotechnology 2013;22:219-27. [DOI: 10.1179/his.1999.22.3.219] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
164 Davis IJ, Perez-atayde AR, Fisher DE. Nonrhabdomyosarcomas and Other Soft Tissue Tumors. Oncology of Infancy and Childhood. Elsevier; 2009. pp. 783-828. [DOI: 10.1016/b978-1-4160-3431-5.00020-0] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
165 Choong PFM, Rydholm A, Mertens F, Mandahl N. Musculoskeletal Oncology: Advances in Cytogenetics and Molecular Genetics and their Clinical Implications. Acta Oncologica 2009;36:245-54. [DOI: 10.3109/02841869709001258] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
166 Brčić I, Rosenberg AE. Pathology of pleomorphic/undifferentiated and dedifferentiated bone neoplasms. Semin Diagn Pathol 2021:S0740-2570(21)00030-7. [PMID: 34049746 DOI: 10.1053/j.semdp.2021.04.005] [Reference Citation Analysis]
167 Czerniak B. Pathologic and molecular aspects of soft tissue sarcomas. Surgical Oncology Clinics of North America 2003;12:263-303. [DOI: 10.1016/s1055-3207(03)00010-3] [Cited by in Crossref: 2] [Article Influence: 0.1] [Reference Citation Analysis]
168 Yoshimoto M, Yamada Y, Ishihara S, Kohashi K, Toda Y, Ito Y, Yamamoto H, Furue M, Nakashima Y, Oda Y. Comparative Study of Myxofibrosarcoma With Undifferentiated Pleomorphic Sarcoma: Histopathologic and Clinicopathologic Review. Am J Surg Pathol 2020;44:87-97. [PMID: 31651522 DOI: 10.1097/PAS.0000000000001389] [Cited by in Crossref: 11] [Cited by in F6Publishing: 4] [Article Influence: 11.0] [Reference Citation Analysis]
169 Rouhani P, Fletcher CDM, Devesa SS, Toro JR. Cutaneous soft tissue sarcoma incidence patterns in the U.S.: An analysis of 12,114 cases. Cancer 2008;113:616-27. [DOI: 10.1002/cncr.23571] [Cited by in Crossref: 178] [Cited by in F6Publishing: 111] [Article Influence: 13.7] [Reference Citation Analysis]
170 Miyajima K, Oda Y, Oshiro Y, Tamiya S, Kinukawa N, Masuda K, Tsuneyoshi M. Clinicopathological prognostic factors in soft tissue leiomyosarcoma: a multivariate analysis: Prognostic factors in leiomyosarcoma. Histopathology 2002;40:353-9. [DOI: 10.1046/j.1365-2559.2002.01361.x] [Cited by in Crossref: 58] [Cited by in F6Publishing: 37] [Article Influence: 3.1] [Reference Citation Analysis]
171 Chandan VS, Fung EK, Woods CI, de la Roza G. Primary pleomorphic liposarcoma of the parotid gland: a case report and review of the literature. Am J Otolaryngol 2004;25:432-7. [PMID: 15547814 DOI: 10.1016/j.amjoto.2004.06.003] [Cited by in Crossref: 18] [Cited by in F6Publishing: 6] [Article Influence: 1.1] [Reference Citation Analysis]
172 Oda Y, Katsuda S, Nakanishi I. An autopsy case of hepatic sarcomatoid tumor: immunohistochemical comparison with a sarcomatous component of hepatocellular carcinoma. Pathol Int 1994;44:230-6. [PMID: 7517764 DOI: 10.1111/j.1440-1827.1994.tb02597.x] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 0.4] [Reference Citation Analysis]
173 Mansoor A, White, CR. Myxofibrosarcoma Presenting in the Skin: Clinicopathological Features and Differential Diagnosis with Cutaneous Myxoid Neoplasms: . The American Journal of Dermatopathology 2003;25:281-6. [DOI: 10.1097/00000372-200308000-00001] [Cited by in Crossref: 58] [Cited by in F6Publishing: 28] [Article Influence: 3.2] [Reference Citation Analysis]
174 Engellau J, Persson A, Bendahl P, �kerman M, Domanski HA, Bjerkehagen B, Lilleng P, Weide J, Rydholm A, Alveg�rd TA, Nilbert M. Expression profiling using tissue microarray in 211 malignant fibrous histiocytomas confirms the prognostic value of Ki-67. Virchows Arch 2004;445:224-30. [DOI: 10.1007/s00428-004-1065-6] [Cited by in Crossref: 14] [Cited by in F6Publishing: 10] [Article Influence: 0.8] [Reference Citation Analysis]
175 Lehnhardt M, Daigeler A, Homann H, Hauser J, Langer S, Steinsträßer L, Soimaru C, Puls A, Steinau H. Die Bedeutung von Referenzzentren in Diagnose und Therapie von Weichgewebssarkomen der Extremitäten: Auswertung von 603 Fällen. Chirurg 2009;80:341-7. [DOI: 10.1007/s00104-008-1562-2] [Cited by in Crossref: 23] [Cited by in F6Publishing: 17] [Article Influence: 1.8] [Reference Citation Analysis]
176 Oda Y, Takahira T, Kawaguchi K, Yamamoto H, Tamiya S, Matsuda S, Tanaka K, Kinukawa N, Iwamoto Y, Tsuneyoshi M. Altered expression of cell cycle regulators in myxofibrosarcoma, with special emphasis on their prognostic implications. Human Pathology 2003;34:1035-42. [DOI: 10.1053/s0046-8177(03)00404-0] [Cited by in Crossref: 29] [Cited by in F6Publishing: 5] [Article Influence: 1.6] [Reference Citation Analysis]
177 Bahrami A, Folpe AL. Adult-type Fibrosarcoma: A Reevaluation of 163 Putative Cases Diagnosed at a Single Institution Over a 48-year Period. American Journal of Surgical Pathology 2010;34:1504-13. [DOI: 10.1097/pas.0b013e3181ef70b6] [Cited by in Crossref: 85] [Cited by in F6Publishing: 17] [Article Influence: 7.7] [Reference Citation Analysis]
178 Weiss SW. 44th Maude Abbott Lecture. Soft tissue sarcomas: lessons from the past, challenges for the future. Mod Pathol 2002;15:77-86. [PMID: 11796845 DOI: 10.1038/modpathol.3880494] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
179 Downes KA, Goldblum JR, Montgomery EA, Fisher C. Pleomorphic liposarcoma: a clinicopathologic analysis of 19 cases. Mod Pathol. 2001;14:179-184. [PMID: 11266523 DOI: 10.1038/modpathol.3880280] [Cited by in Crossref: 95] [Cited by in F6Publishing: 59] [Article Influence: 4.8] [Reference Citation Analysis]
180 Ferrari A, Alaggio R, Ferrari S. Rare Mesenchymal Tumors. In: Schneider DT, Brecht IB, Olson TA, Ferrari A, editors. Rare Tumors In Children and Adolescents. Berlin: Springer Berlin Heidelberg; 2012. pp. 485-517. [DOI: 10.1007/978-3-642-04197-6_44] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
181 Kikuta K, Morioka H, Kawai A, Kondo T. Global protein-expression profiling for reclassification of malignant fibrous histiocytoma. Biochim Biophys Acta 2015;1854:696-701. [PMID: 25173742 DOI: 10.1016/j.bbapap.2014.08.012] [Cited by in Crossref: 2] [Article Influence: 0.3] [Reference Citation Analysis]
182 Baheti AD, O'Malley RB, Kim S, Keraliya AR, Tirumani SH, Ramaiya NH, Wang CL. Soft-Tissue Sarcomas: An Update for Radiologists Based on the Revised 2013 World Health Organization Classification. AJR Am J Roentgenol 2016;206:924-32. [PMID: 26998884 DOI: 10.2214/AJR.15.15498] [Cited by in Crossref: 19] [Cited by in F6Publishing: 6] [Article Influence: 3.8] [Reference Citation Analysis]
183 Skubitz KM, D'Adamo DR. Sarcoma. Mayo Clin Proc 2007;82:1409-32. [PMID: 17976362 DOI: 10.4065/82.11.1409] [Cited by in Crossref: 182] [Cited by in F6Publishing: 120] [Article Influence: 13.0] [Reference Citation Analysis]
184 Martignetti JA, Gelb BD, Pierce H, Picci P, Desnick RJ. Malignant fibrous histiocytoma: Inherited and sporadic forms have loss of heterozygosity at chromosome bands 9p21-22?evidence for a common genetic defect. Genes Chromosom Cancer 2000;27:191-5. [DOI: 10.1002/(sici)1098-2264(200002)27:2<191::aid-gcc11>3.0.co;2-l] [Cited by in Crossref: 27] [Article Influence: 1.3] [Reference Citation Analysis]
185 Mertens F, Fletcher CDM, Dal Cin P, De Wever I, Mandahl N, Mitelman F, Rosai J, Rydholm A, Sciot R, Tallini G, Van den Berghe H, Vanni R, Willén H. Cytogenetic analysis of 46 pleomorphic soft tissue sarcomas and correlation with morphologic and clinical features: A report of the CHAMP study group. Genes Chromosom Cancer 1998;22:16-25. [DOI: 10.1002/(sici)1098-2264(199805)22:1<16::aid-gcc3>3.0.co;2-a] [Cited by in Crossref: 135] [Cited by in F6Publishing: 24] [Article Influence: 5.9] [Reference Citation Analysis]
186 Wu JM, Montgomery E. Classification and pathology. Surg Clin North Am. 2008;88:483-520, v-vi. [PMID: 18514695 DOI: 10.1016/j.suc.2008.03.007] [Cited by in Crossref: 22] [Cited by in F6Publishing: 12] [Article Influence: 1.7] [Reference Citation Analysis]
187 Meis-Kindblom JM, Bjerkehage B, Böhling T, Domanski H, Halvorsen TB, Larsson O, Lilleng P, Myhre-Jensen O, Stenwig E, Virolainen M, Willén H, Akerman M, Kindblom LG. Morphologic review of 1000 soft tissue sarcomas from the Scandinavian Sarcoma Group (SSG) Register. The peer-review committee experience. Acta Orthop Scand Suppl 1999;285:18-26. [PMID: 10429617 DOI: 10.1080/17453674.1999.11744818] [Cited by in Crossref: 35] [Cited by in F6Publishing: 28] [Article Influence: 1.6] [Reference Citation Analysis]